News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
AIEOP’s 16th AYA Oncology Newsletter: An investigation from the Italian AYA Working group
AIEOP/aieop.org
Apr 13, 2025, 13:29

AIEOP’s 16th AYA Oncology Newsletter: An investigation from the Italian AYA Working group

AIEOP: The Italian Association of Pediatric Hematology and Oncology, shared a post on LinkedIn:

“AIEOP Adolescent Working Group’s 16th AYA Oncology Newsletter is out!

This newsletter focuses on a study conducted by​ AIOM | The Italian Association of Medical Oncology and AIEOP joint group dedicated to adolescents and young adults.

Article was written by Toss et al. and published in the European Journal of Cancer (EJC):

“Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group”

Original article here”

AIEOP

Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group

Authors: Angela Toss et al.

AIEOP's 16th AYA Oncology Newsletter: An investigation from the Italian AYA Working group

Learn more about early-onset cancer and AYA oncology on OncoDaily.

AIOM Andrea Ferrarini Angela Toss Annalisa Trama AYA oncology AYA Oncology Newsletter cancer Claudia Piombino early-onset cancer EJC Fedro Peccatori Francesco Perrone Giuseppe Maria Milano Lorena Incorvaia Marco Maruzzo Marta Canesi Matteo Lambertini Maurizio Mascarin OncoDaily Oncology Paola Quarello
Special Coverage
Insight
Apr 15, 2025, 09:02
WHO’s Andre Ilbawi Highlights Global Cancer Medicine Access Challenges
Insight
Apr 15, 2025, 08:45
Guillermo Chantada Opens the Forum on Essential Medicines for Children with Cancer
Blog
Apr 15, 2025, 08:23
Stephen V Liu: Taletrectinib and zidesamtinib promise to move the field of ROS1 NSCLC by addressing resistance and safety
Positive
Apr 15, 2025, 08:03
Rawan Hammad: Thank you to the speakers, moderators, organizers and attendees who made SIOP Asia Riyadh 2025 a success!
Blog
Apr 15, 2025, 07:52
Basel Refky: Presenting in Lebanon, Masterclass in Cairo, and a Publication — A Tough Weekend but Fruitful
Blog
Apr 15, 2025, 07:52
Luchuo Engelbert Bain: The Future is bright - African medical students taking their future into their hands
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025